EN DE
Research & Education

Springer Nature AG & Co KGaA Fair Value Analysis: Valuation and Q

2026-08-10 · fairvalue-calculator.com
Dr. Peter Klein By Dr. Peter Klein, BA · Founder

Springer Nature AG & Co KGaA Fair Value Analysis

Springer Nature AG & Co KGaA operates as a leading global academic publisher with core segments in research, education and health. Its portfolio includes flagship titles such as Nature and Springer journals that deliver high margin recurring revenue through subscriptions and open access models. At a recent price of EUR 20.25 the stock appears undervalued against our fair value estimate of EUR 30.5, which implies meaningful upside potential while carrying a quality score of 74 out of 100.

Recent Performance and Market Context

The company delivered strong results through 2025 and into the first half of 2026. Revenue reached EUR 1,926.4 million for the full year 2025 with 6.2 percent underlying growth. Adjusted operating profit also rose solidly. Management guided for continued 5 to 6 percent underlying revenue growth in 2026 together with a modest margin expansion. Momentum in the research segment, driven by open access demand and institutional subscriptions, underpins these figures.

Key Valuation Drivers

Our fair value assessment incorporates projected earnings growth, stable high gross margins above 85 percent and the durable competitive position in scientific publishing. Key inputs include continued expansion of open access offerings, pricing power in premium journals and operational leverage from digital platforms. The resulting EUR 30.5 target reflects these elements discounted appropriately for sector dynamics and capital structure.

💡 Theory is good, numbers are better. Get the fair value of any stock worldwide in seconds. Try it free →

Investors can explore detailed assumptions and run custom scenarios with the fair value calculator on this site.

Main Risks to Consider

  • Potential pressure on institutional library budgets amid broader economic uncertainty.
  • Accelerated transition to fully open access models that could compress subscription revenue in the medium term.
  • Competition from emerging platforms and AI driven content tools that may alter traditional publishing economics.
  • Currency fluctuations given significant international revenue exposure.

Balanced Verdict

Springer Nature AG & Co KGaA combines resilient cash flows with attractive growth prospects in a high quality publishing franchise. The current discount to our fair value of EUR 30.5 suggests the market has not fully priced in recent execution strength and forward guidance. At a quality score of 74 the business demonstrates above average durability, yet risks around funding cycles and industry evolution warrant ongoing monitoring. This analysis is for informational purposes only and is not financial advice.

Check the latest inputs and compare Springer Nature AG & Co KGaA against peers using the free Fair Value Calculator.

Frequently Asked Questions

What is the current fair value estimate for Springer Nature AG & Co KGaA?

Our model places the fair value of Springer Nature AG & Co KGaA at EUR 30.5 compared with the recent share price of EUR 20.25.

Why does Springer Nature AG & Co KGaA have a quality score of 74 out of 100?

The score reflects a solid business model in research publishing, strong brand assets in journals such as Nature and consistent earnings quality alongside moderate leverage.

What are the main risks for investors in Springer Nature AG & Co KGaA?

Key risks include shifts in academic funding, the pace of open access transitions, competition from new platforms and potential regulatory changes affecting publishing margins.

Sources

Context gathered via live web search while writing this article:

Check the fair value of any stock worldwide
21 valuation models · 35,000+ stocks · evidence-based
Start free →